Items where Author is "Drummond, Michael"

Number of items: 30.
Article
  • The effect of bearing surface on cementless and hybrid total hip arthroplasty survival:an updated analysis of contemporary bearing data from the National Joint Registry and hospital episode statistics. (2025) Pagkalos, Joseph; Raikou, Maria; Drummond, Michael; McGuire, Alistair; Davis, Edward
  • LSE–Lancet Commission on the future of the NHS:re-laying the foundations for an equitable and efficient health and care service after COVID-19. (2021) Anderson, Michael; Pitchforth, Emma; Asaria, Miqdad; Brayne, Carol; Casadei, Barbara; Charlesworth, Anita; Coulter, Angela; Franklin, Bryony Dean; Donaldson, Cam; Drummond, Michael; Dunnell, Karen; Foster, Margaret; Hussey, Ruth; Johnson, Paul; Johnston-webber, Charlotte; Knapp, Martin; Lavery, Gavin; Longley, Marcus; Clark, Jill Macleod; Majeed, Azeem; Mckee, Martin; Newton, John N; O'neill, Ciaran; Raine, Rosalind; Richards, Mike; Sheikh, Aziz; Smith, Peter; Street, Andrew; Taylor, David; Watt, Richard G; Whyte, Moira; Woods, Michael; Mcguire, Alistair; Mossialos, Elias picture_as_pdf
  • An EU-wide approach to HTA:an irrelevant development or an opportunity not to be missed? (2019) Kanavos, Panos; Angelis, Aris; Drummond, Michael
  • Impact of reimbursement policies on the adoption of medical devices in an outpatient setting. (2014) Wilkinson, Grahame; Drummond, Michael
  • Improving medical device regulation: the United States and Europe in perspective. (2014) Sorenson, Corinna; Drummond, Michael
  • Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. (2013) Sorenson, Corinna; Drummond, Michael; Wilkinson, Grahame
  • Medical technology as a key driver of rising health expenditures: disentangling the relationship. (2013) Sorenson, Corinna; Drummond, Michael; Bhuiyan Kahn, Beena
  • Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. (2013) Sorenson, Corinna; Drummond, Michael; Burns, Lawton R.
  • Applying health economics for policy decision making: how much do devices differ from drugs? (2011) Sorenson, Corinna; Tarricone, Rosanna; Siebert, Markus; Drummond, Michael
  • Nasty or nice?: a perspective on the use of health technology assessment in the United Kingdom. (2009) Drummond, Michael; Sorenson, Corinna
  • Can NICE be nicer?: in a world of budget constraints there are no easy solutions. (2009) Drummond, Michael; Sorenson, Corinna
  • Toward a consensus on the QALY. (2009) Drummond, Michael; Brixner, Diana; Gold, Marthe; Kind, Paul; McGuire, Alistair; Nord, Erik
  • Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? (2008) Sorenson, Corinna; Drummond, Michael; Kanavos, Panos; McGuire, Alistair
  • Selection of end points in economic evaluations of coronary heart disease interventions. (1993) McGuire, Alistair; Drummond, Michael; Heyse, Joseph; Cook, John
  • The economic burden of treated benign prostatic hyperplasia in the UK. (1993) McGuire, Alistair; Drummond, Michael; Black, N.; Pettigrew, M.; McPherson, K.
  • Economic evaluation in health care: an introduction for psychiatrists. (1993) McGuire, Alistair; Drummond, Michael
  • Selection of end points in economic evaluations of coronary heart disease interventions: application to Canadian data. (1993) McGuire, Alistair; Cook, John; Drummond, Michael; Heyse, Joseph
  • How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard picture_as_pdf
  • Promoting innovation while controlling cost:the UK’s approach to health technology assessment. Anderson, Michael; Drummond, Michael; Taylor, David; Mcguire, Alistair; Carter, Paul; Mossialos, Elias picture_as_pdf
    • Chapter
  • Economic evidence. (2019) Shemilt, Ian; Aluko, Patricia; Graybill, Erin; Craig, Dawn; Henderson, Catherine; Drummond, Michael; Wilson, Edward CF; Robalino, Shannon; Vale, Luke
  • Measuring value: pharmacoeconomics theory and practice. (2012) Towse, A; Drummond, Michael; Sorenson, Corinna
  • Use of pharmacoeconomics in drug reimbursement in Australia, Canada and the UK: what can we learn from international experience? (2009) Drummond, Michael; Sorenson, Corinna
  • Incorporating economics evidence. (2008) Shemilt, Ian; Mugford, Miranda; Byford, Sarah; Drummond, Michael; Eisenstein, Eric; Knapp, Martin; Mallender, Jacqueline; McDaid, David; Vale, Luke; Walker, Damian
  • Reimbursement of pharmaceuticals in the European Union. (2004) McGuire, Alistair; Drummond, Michael; Rutten, Frans
  • The cost-effectiveness of lipid-lowering drugs. (1990) McGuire, Alistair; Drummond, Michael
    • Conference or Workshop Item
  • Ensuring value for money in health care: The role of HTA in the European Union. (2007) Sorenson, Corinna; Drummond, Michael; Kanavos, Panos
    • Report
  • Measuring value: pharmacoeconomics in theory and practice. (2011) Towse, Adrian; Drummond, Michael; Sorenson, Corinna
  • National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? (2008) Sorenson, Corinna; Drummond, Michael; Kanavos, Panos; McGuire, Alistair
  • How can European health systems support investment in and the implementation of population health strategies? (2008) McDaid, David; Drummond, Michael; Suhrcke, Marc
  • How can the impact of health technology assessments be enhanced? (2008) Sorenson, Corinna; Drummond, Michael; Kristensen, Finn Børlum; Busse, Reinhard